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While initially recognized as causing respiratory disease, the SARS-CoV-2
virus also affects many other organs leading to other complications. It has
emerged that advanced age and obesity are risk factors for complications
but questions concerning the potential effects on fetal health and successful
pregnancy for those infected with SARS-CoV-2 remain largely unanswered.
Here, we examine human pre-gastrulation embryos to determine the
expression patterns of the genes ACE2, encoding the SARS-CoV-2 receptor,
and TMPRSS2, encoding a protease that cleaves both the viral spike protein
and the ACE2 receptor to facilitate infection. We show expression and
co-expression of these genes in the trophoblast of the blastocyst and syncy-
tiotrophoblast and hypoblast of the implantation stages, which develop into
tissues that interact with the maternal blood supply for nutrient exchange.
Expression of ACE2 and TMPRSS2 in these tissues raises the possibility
for vertical transmission and indicates that further work is required to
understand potential risks to implantation, placental health and fetal
health that require further study.1. Introduction
Beginning in December 2019, the novel coronavirus SARS-CoV-2 spread
rapidly throughout the world population. It rapidly became clear that the
virus has widespread effects upon many tissues and that thromboembolic
events are the major cause of death. However, the consequences of infection
for the unborn child are largely unaddressed.
Conflicting clinical reports have emerged regarding SARS-CoV-2 infection
in neonates whose mothers were infected. Some studies have found no evi-
dence for vertical transmission, while others found a percentage of neonates
to be born with SARS-CoV-2 infection [1–3]. Although, some of these positive
neonate cases could arise through viral transmission shortly after birth, at least
one appears due to vertical transmission in the third trimester [3]. All these
clinical studies have involved pregnant individuals whose SARS-CoV-2 infec-
tion was detected during the third trimester. Much less is known concerning
the risks of vertical transmissionat at earlier stages. With these considerations
in mind, we address here when in human development is the earliest stage at
which SARS-CoV-2 receptor, angiotensin-converting enzyme 2 (ACE2), is first
expressed and therefore when the human embryo could possibly become
infected.
Following fertilization, the single-cell zygote undergoes rapid cleavage div-
isions. On day 5 after fertilization, the blastocyst is formed, which will implant
into the uterus on the following day (figure 1a). The early embryo at this stage
is comprised trophoblast cells, which will give rise to the placenta to connect
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Figure 1. (Caption overleaf.)
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Figure 1. (Overleaf.) Expression of ACE2 and TMPRSS2 in the pre-gastrulation human embryo. (a) Schematics of the D6/7 late blastocyst and D11/12 pre-gastrula
embryo. (b) uniform manifold approximation and projection (UMAP) of integrated published post-implantation RNA-sequencing datasets. (c) UMAP of integrated
dataset labelled by timepoint. (d ) UMAP of integrated dataset with expression levels of epiblast markers (SOX2, POU5F1, NANOG), hypoblast markers (GATA4, GATA6,
FOXA2) and trophoblast markers (GATA3 for pan-trophoblast, HLA-G for extravillous trophoblast, SDC1 for syncytiotrophoblast) in TPM. (e) UMAP of integrated dataset
labelled by cell-type cluster. ( f ) UMAP of integrated dataset with expression levels of ACE2 in TPM. (g) UMAP of integrated dataset with expression levels of
TMPRSS2 in TPM. (h) UMAP of isolated integrated hypoblast, trophoblast and syncytiotrophoblast clusters with expression and co-expression of ACE2 and
TMPRSS2. EPI = epiblast, HYPO = hypoblast, TE = trophectoderm, TrB = Trophoblast, STB = syncytiotrophoblast, EVT = extravillous trophoblast.
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the developing fetus with the mother, hypoblast cells, which
will give rise to the yolk sac, and epiblast cells which will
give rise to both the amniotic epithelium (precursor of the
amniotic sac) and the baby itself. Following implantation, the
embryo undergoes a series of morphological and genetic
changes. These include differentiation of large multinucleated
syncytiotrophoblasts (derived from the trophoblast), which
will contribute to the formation of connections with maternal
blood vessels; differentiation of extravillous trophoblast,
which will grow out from the placenta and penetrate into the
decidualized uterus; and expansion of the hypoblast to form
the primary yolk sac, important to establish the early embryo-
nic blood supply (figure 1b). At day 14, the part of the epiblast
undergoes gastrulation, during which the three germ lineages
are formed that will give rise to all tissues in the baby. These
stages of early development are complex and delicate. Despite
the remarkable plasticity of the embryo, it is particularly vul-
nerable at this time with about 60% of pregnancies failing
during these first 14 days of development [4,5].
Recently, a culture platform has been developed that per-
mits the growth of surplus IVF human embryos up to day 14
[6–8]. This platform permits for the first time the exploration
of gene expression patterns that provide signatures for all
distinct cell types in the human embryo until the end of the
second week of pregnancy. To gain a global view of gene
expression in the different cell types of the human embryo,
we have combined and analysed single-cell RNA-sequencing
data available so far, including our own data [8,9], using the
Seurat v3.1 integration protocol with 10 000 anchor points
(figure 1b,c). We subjected this integrated data to clustering
using principal component analysis and nearest neighbour
approximation in 10 dimensions, which identified 5 clusters
(figure 1d,e). The presence (+) or absence (−) of canonical
marker gene expression identified these clusters as represent-
ing five cell types: a SOX2+ POU5F1+ NANOG+ epiblast
cluster; a GATA4+ GATA6+ FOXA2+ hypoblast cluster; a
GATA3+ HLAG- SDC1- trophoblast cluster; a GATA3+
HLAG- SDC1+ syncytiotrophoblast cluster and a GATA3+
HLAG+SDC1- extravillous trophoblast cluster (figure 1d,e).
SARS-CoV-2 entry into a cell involves the interaction of its
spike protein with the cell’s membrane-bound angiotensin-
converting enzyme 2 (ACE2), which is cleaved by the
transmembrane protease serine 2 (TMPRSS2) [10]. Blocking
TMPRSS2 protease activity blocks ACE2-mediated entry of
SARS-CoV-2 [10], suggesting that co-expression of both
genes is required for infection. We, therefore, sought to
determine the expression patterns of ACE2 and TMPRSS2 in
the integrated RNA-sequencing dataset. Visualizing ACE2
expression across all lineages revealed its enrichment in the
day 6 and day 7 trophoblast (31.4% expressed), day 12 and
day 14 syncytiotrophoblast (26.8% expressed) and hypoblast
cells (21.5% expressed) (figure 1f ). Visualizing TMPRSS2
expression, revealed a similar, though more wide-spreadpattern, in addition to expression in 32.8% of epiblast cells
(figure 1g). We could detect the strong co-localization of
expression of both genes 25.5% of the blastocyst trophoblast,
as well as in 21.8% of syncytiotrophoblast (figure 1h).
Co-localization in hypoblast cells was weaker, though still
present in 7.2% of cells. Overall this analysis indicates that a
subset of cells across different trophoblast and hypoblast
lineages may be susceptible to SARS-CoV-2 infection.
The expression of ACE2 and TMPRSS2 in the hypoblast
and syncytiotrophoblast may be hypothesized due to the role
of ACE2 in attenuating ACE activity during the regulation of
angiotensin cleavage in vasoconstriction [11]. Thus, ACE2
may be anticipated to function in the early development of
the embryo’s blood system enabling nutrient and oxygen
exchange with the mother. After gastrulation, the yolk sac
derived from the hypoblast gives rise to blood islands that
will form capillaries close to maternal blood surrounding the
embryo [12]. Later, the placenta, derived from the trophoblast,
particularly syncytiotrophoblast, will be surrounded by
maternal blood and will take over nutrient exchange. Thus,
these derivatives of hypoblast and trophoblast come to exist
close to and exchange nutrients with the maternal blood. The
expression of ACE2 and TMPRSS2 in these tissues, therefore,
raises the possibility of vertical transmission during these
very early stages of human development when the majority
of pregnancies remain unnoticed.
In addition to ACE2 and TMPRSS2, other potential SARS-
CoV-2 receptors, proteases and cofactors for infection have
been suggested, including BSG (CD147) [13] and NRP1 [14]
as receptors, and CTSL as a key protease [15]. Importantly,
each of these are also expressed in the pre-gastrulation
embryo. BSG and CTSL are expressed in all tissues (sup-
plementary figure 1a-b), while NRP1 is enriched in the
trophoblast (supplementary figure 1c). This suggests the
possibility of multiple avenues through which SARS-CoV-2
may infect the early embryo.
The potential of viral infection through transmission of
SARS-CoV-2 during early pregnancy via maternal blood
can have implications for the success of implantation:
future placental and fetal health. Our findings greatly
extend another study indicating the expression of ACE2
during later stages of placental development as well as in
fetal organs such as the heart, liver and lung [16]. Impor-
tantly, these analyses are based on RNA expression and
therefore are not validated at the protein level. Nevertheless,
our present study offers an indication that the potential effect
of SARS-CoV-2 infection on the early embryo should be
further investigated using both stem cell models of the
embryo and in non-human primates.
Data accessibility. Single cell RNA-sequencing data are deposited in
Gene Expression Omnibus (GEO) under accession numbers
GSE136447 and GSE109555.
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